Dyadic strategy training for stroke survivors and their caregivers
A Novel Rehabilitation Approach for Optimizing Dyadic Outcomes of Stroke Survivors and Their Caregivers: Dyadic Strategy Training
This study tests a new training program designed to help stroke survivors and their caregivers work better together and improve their daily activities.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 138 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Taipei Medical University Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Taipei) |
| Trial ID | NCT05571150 on ClinicalTrials.gov |
What this trial studies
This study examines the effectiveness of a new dyad-focused strategy training intervention aimed at improving participation for stroke survivors and their caregivers. It employs a single-blinded, parallel-group randomized controlled design, comparing the intervention group to a control group. A total of 138 stroke survivor-caregiver dyads will be recruited from hospitals in Northern Taiwan, with data analyzed using multiple linear regression and mixed-effects models. Qualitative interviews will also be conducted to gather in-depth insights from participants post-intervention.
Who should consider this trial
Good fit: Ideal candidates include stroke survivors aged 20 and older who have had a first-time stroke within the past two years and have a primary caregiver who speaks Mandarin.
Not a fit: Patients who require significant medical treatment or have severe aphasia or dementia may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life and social participation for both stroke survivors and their caregivers.
How similar studies have performed: While dyad-focused interventions are emerging, this specific approach is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Stroke survivors 1. ages 20 years and older; 2. has been diagnosed with a first-time stroke within the past two year; 3. speaks Mandarin; 4. has an identified primary caregiver who provides care or assistance of any kind and taking responsibility for the survivor; 5. is able to provide informed consent. * Family caregivers include that the caregiver 1. ages 20 years and older; 2. speaks Mandarin; 3. is the primary caregiver recognized by the survivor; 4. is available to participate in the intervention sessions with the survivor; 5. is able to provide informed consent. Exclusion Criteria: * The survivor-caregiver dyad will be excluded if any of them: 1. requires significant medical treatment (e.g., chemotherapy, radiation therapy, or hemo/peritoneal dialysis) that may impede them from participating in the study; 2. has severe aphasia; 3. is unable to participate in a 1-hour discussion session; 4. has a diagnosis of dementia, major depressive disorder, substance use or other psychiatric disorders that may impede them from participating in the study.
Where this trial is running
Taipei
- Taipei Medical University — Taipei, Taiwan (Recruiting)
Study contacts
- Principal investigator: Feng-Hang Chang — Taipei Medical University
- Study coordinator: Feng-Hang Chang, Sc.D.
- Email: fhchang@tmu.edu.tw
- Phone: 886-2-2736-1661
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.